DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections

Information source: Hillel Yaffe Medical Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Surgical Wound Infection; Cesarean Section; Staphylococcus Aureus

Intervention: Mupirocin (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Hillel Yaffe Medical Center


The investigators believe that irradication of nose colonization of staphyloccocus aureus will reduce the incidence of surgical site infections after cesarean section.

Clinical Details

Study design: Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Reduction of the incidence of surgical site infections after cesarean section


Minimum age: N/A. Maximum age: N/A. Gender(s): Female.


Inclusion Criteria:

- Women assigned to undergo cesarean section

Exclusion Criteria:

- All others

Locations and Contacts

Hillel Yaffe Medical Center, Hadera 38100, Israel; Not yet recruiting
Gai Shrem, MD, Email: gais@hy.health.gov.il
Gai Shrem, MD, Principal Investigator
Additional Information

Starting date: July 2010
Last updated: June 28, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017